We thus reasoned that LCN2 might play a role in mediating celastrol’s anorexigenic and anti-obesity effect, such that LCN2 deficiency would reduce celastrol’s anorexigenic effects, and blunt the ability of celastrol to reduce body weight in DIO mice. Here, LCN2 is linked to obesity due to melanocortin 4 receptor deficiency.